Récemment recherché

Aucun résultat trouvé

Étiquettes

Aucun résultat trouvé

Document

Aucun résultat trouvé

Accueil Écoles Thèmes

Connexion

The use of delamanid in the treatment of multidrug-resistant tuberculosis

Partager "The use of delamanid in the treatment of multidrug-resistant tuberculosis"

N/A

N/A

Protected

Année scolaire: 2022

Info

Protected

Academic year: 2022

Partager "The use of delamanid in the treatment of multidrug-resistant tuberculosis"

Copied!

80

0

0

80

0

0

Chargement.... (Voir le texte intégral maintenant)

Télécharger maintenant ( 80 Page )

Texte intégral

Références

Télécharger maintenant ( PDF - 80 Page - 531.37 KB )

Documents relatifs

Documents relatifs

Shortened multidrug-resistant tuberculosis treatment in settings with a high prevalence of ofloxacin resistance: Ofloxacin resistance and shortened MDR-TB treatment

Shortened multidrug-resistant tuberculosis treatment in settings with a high prevalence of ofloxacin resistance: Ofloxacin resistance and shortened MDR-TB treatment

7

0

0

WHO best-practice statement on the off-label use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis

WHO best-practice statement on the off-label use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis

9

0

0

The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents

The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents

58

0

0

The use of bedaquiline in the treatment of multidrug-resistant tuberculosis

The use of bedaquiline in the treatment of multidrug-resistant tuberculosis

64

0

0

Report of the Guideline Development Group Meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis

Report of the Guideline Development Group Meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis

64

0

0